Avadel Pharmaceuticals PLC (AVDL) Stock Balance Sheet
NASDAQ:AVDL • IE00BDGMC594
Current stock price
21.64 USD
+0.01 (+0.05%)
At close:
21.65 USD
+0.01 (+0.05%)
After Hours:
| MRQ (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 79.81M | 51.37M | 31.17M | 73.98M | 50.71M | |||
| Marketable Securities | 11.76M | 22.41M | 73.94M | 22.52M | 106.51M | |||
| Receivables | 42.44M | 34.10M | 13.43M | 2.59M | 31.82M | |||
| Inventories | 23.91M | 20.30M | 10.38M | N/A | N/A | |||
| Other Current Assets | 14.30M | 6.04M | 5.29M | 1.75M | 3.45M | |||
| Total Current Assets | 172.23M | 134.21M | 134.20M | 100.84M | 192.49M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.01M | 2.15M | 3.18M | 2.55M | 2.94M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 16.84M | 16.84M | 16.84M | 16.84M | 16.84M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 7.38M | 11.04M | 10.15M | 11.32M | 33.78M | |||
| Total Non-Current Assets | 27.22M | 30.03M | 30.50M | 31.94M | 54.77M | |||
| TOTAL ASSETS | 199.45M | 164.24M | 164.70M | 132.78M | 247.26M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 0.00 | 37.67M | N/A | |||
| Accrued Expenses | 44.90M | 41.23M | 25.16M | 9.94M | 12.75M | |||
| Accounts Payable | 12.58M | 7.33M | 11.43M | 7.89M | 7.68M | |||
| Other Current Liabilities | 5.01M | 273.00K | 261.00K | 292.00K | 567.00K | |||
| Total Current Liabilities | 62.49M | 48.83M | 36.85M | 55.79M | 21.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 34.83M | 35.25M | 0.00 | 91.61M | 142.40M | |||
| Other Non-Current Liabilities | 3.91M | 6.30M | 40.10M | 6.52M | 5.62M | |||
| Total Non-Current Liabilities | 38.74M | 41.55M | 40.10M | 98.14M | 148.02M | |||
| TOTAL LIABILITIES | 101.22M | 90.39M | 76.96M | 153.93M | 169.02M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -789.56M | -794.33M | -745.50M | -585.22M | -447.76M | |||
| Additional Paid In Capital | 910.39M | 891.79M | 855.45M | 589.78M | 549.35M | |||
| Common Shares | 972.00K | 965.00K | 950.00K | 633.00K | 591.00K | |||
| Treasury Stock | N/A | N/A | N/A | N/A | N/A | |||
| Other Shareholders' Equity | -23.66M | -24.74M | -24.12M | -24.45M | -23.86M | |||
| Shares Outstanding | 86.96M | 86.32M | 80.34M | 56.24M | 52.43M | |||
| Tangible Book Value per Share | 0.84 | 0.59 | 0.79 | -0.60 | 1.05 | |||
| Total Shareholders' Equity | 98.22M | 73.85M | 87.74M | -21.14M | 78.24M | |||
| TOTAL LIABILITIES AND EQUITY | 199.45M | 164.24M | 164.70M | 132.78M | 247.26M | |||
| Statistics | ||||||||
| Debt/Equity | 0.35 | 0.48 | N/A | -4.33 | 1.82 | |||
| Current Ratio | 2.76 | 2.75 | 3.64 | 1.81 | 9.17 | |||
| Return On Assets (ROA) | -0.14% | -29.73% | -97.32% | -103.52% | -31.27% | |||
| Return On Equity (ROE) | -0.28% | -66.13% | -182.67% | N/A | -98.83% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21